Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 3, 2013, Pages 347-353

  Danna, Paolo ^a   Proietti, Riccardo ^a   Sagone, Antonio ^a   Arensi, Andrea ^a   Viecca, Maurizio ^a   Rago, Anna ^b   Russo, Vincenzo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

atrial fibrillation; device; left atrial appendage closure; new technology; oral anticoagulation; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CEFTRIAXONE; CLOPIDOGREL; HEPARIN; WARFARIN;

AGED; AMPLATZER CARDIAC PLUG; ANEMIA; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHADS2 VASC SCORE; CLINICAL EVALUATION; CONTROLLED STUDY; DEVICE EMBOLISM; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIAL APPENDAGE; HEART PACING; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PATIENT SELECTION; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; POSTOPERATIVE INFECTION; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SEPTAL OCCLUDER; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE;

EID: 84874783329     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12058     Document Type: Article

References (34)

1. Guidelines for the management of atrial fibrillation. European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
2. Wolf PA, Abbott RD, Kannel WB,. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
3. Wolf PA, Dawber TR, Thomas HE, Kannel WB,. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 1978; 28: 973-977.
4. Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
5. Leithauser B, Park JW,. Cardioembolic stroke in atrial fibrillation-Rational for preventive closure of the left atrial appendage. Korean Circ J 2009; 39: 443-458.
6. Waldo AL, Becker RC, Tapson VF, Colgan KJ,. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005; 46: 1729-1736.
7. Birman-Deych E, Radford MJ, Nilasena DS, Gage BF,. Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation. Stroke 2006; 37: 1070-1074.
8. Onalan O, Crystal E., Left atrial appendage exclusion for stroke prevention in patients with Nonrheumatic atrial fibrillation. Stroke 2007; 38: 624-630.
9. Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation-Initial European experience. Catheter Cardiovasc Interv 2011 77; 5: 700-706.
10. Lam YY, Yip GWK, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, et al. Left atrial appendage closure with Amplatzer Cardiac Plug for stroke prevention in atrial fibrillation: Initial Asia-Pacific experience. Catheter Cardiovasc Interv 2011. doi: 10.1002/ccd.23136
11. Montenegro MJ, Quintella EF, Damonte A, Sabino HD, Zajdenverg R, Laufer GP, Amorim B, et al. Percutaneous occlusion of left atrial appendage with the Amplatzer Cardiac PlugTM in atrial fibrillation. Arq Bras Cardiol 2012; 98: 143-150.
12. Block PC, Burstein S, Casale PN,. Percutaneous left atrial appendage transcatheter occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-years results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study. JACC Cardiovasc Interv 2009; 2: 594-600.
13. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non inferiority trial. Lancet 2009, 374: 534-542.
14. Lee RJ, Bartus K, Yakubov SJ,. Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: Initial experience in a canine model. Circ Cardiovasc Interv 2010; 3: 224-229.
15. Ganjehei L, Massumi A, Razavi M, Rasekh A,. Stroke prevention in nonvalvular atrial fibrillation. Tex Heart Inst J 2011; 38: 350-352.
16. Lee RJ, Bartus K, Bednarek J, Lelakowski J, Myc J, Kapelak B, Sadowski J, et al. Long-term efficacy of a percutaneous approach for LAA ligation in patients with atrial fibrillation. Heart Rhythm 2011; 8: S379-S380.
17. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S,. Safety of percutaneous left atrial appendage closure: Results from the Watchamn Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123: 417-424.
18. Sayed HM, Dacie JV, Handley DA, et al. Hemolytic anemia of mechanical origin after open heart surgery. Thorax 1961; 16: 356-360.
19. Marsh GW,. Intravascular hemolytic anemia after aortic valve replacement. Lancet 1964; 2: 986-988.
20. Nitter-Hauge S, Sommerfelt SC, Hall K-V, Fröysaker T, Efskind L., Chronic intravascular hemolysis after aortic disc valve replacement. Comparative study between Lillehei-Kaster and Bjork-Shiley disc valve prostheses. Br Heart J 1974; 36: 781-785.
21. Nitter-Hauge S,. Hemolysis after mitral valve replacement with the Bjork- Shiley and the Lillehei-Kaster disc valve prostheses. Br Heart J 1976; 38: 977-980.
22. Grosse-Brockhoff F, Gehrmann G,. Mechanical hemolysis in patients with valvular heart disease and valve prosthesis. Am Heart J 1967; 74: 137-139.
23. Weesner KM, Rocchini AP, Rosenthal A, Behrendt D,. Intravascular hemolysis associated with porcine mitral valve calcification in children. Am J Cardiol 1981; 47: 1286-1288.
24. Magilligan DJ, Fisher E, Alam M,. Hemolytic anemia with porcine xenograft aortic and mitral valves. Thorac Cardiovasc Surg 1980; 79: 628-631.
25. Gupta SC, Suryaprasad AG,. Mechanical hemolytic anemia after repair of ruptured chordae tendineae of mitral valve-apparatus. Angiology 1979; 30: 776-779.
26. Moisey CU, Manohitharajah SM, Tovey LAD, Deverall PB,. Hemolytic anemia in a child in association with congenital mitral valve disease. J Thorac Cardiovasc Surg 1972; 63: 765-768.
27. Mok P, Lieberman EH, Lilly LS, Schafer AI, DiSesa VJ, Rutherford CR., Severe hemolytic anemia following mitral valve repair. Am Heart J 1989; 117: 1171-1173.
28. Warnes C, Honey M, Brooks N, Davies J, Gorman A, Parker N., Mechanical hemolytic anemia after valve repair operations for nonrheumatic mitral regurgitation. Br Heart J 1980; 44: 381-385. horac Surg 1992; 6:103-105.
29. Wilson JH, Rath R, Glaser R, Panke T,. Severe hemolysis after incomplete mitral valve repair. Ann Thorac Surg 1990; 50: 136-137.
30. Dilip KA, Vachaspathy P, Clarke B, Walker DM, Thomas RD, Monro JL., Hemolysis following mitral valve repair. J Cardiovasc Surg 1992; 33: 568-659.
31. Mestres CA, Soo CS, Sim EKW, Adebo OA, Yan P, Lee CN., Intravascular hemolysis after mitral valve repair: A word of caution. Eur J Cardiothorac Surg.
32. Stoschitzky K, Starz I, Anelli-Monti M, Rigler B, Bauer F, Klein W., Transfusion-requiring hemolytic anemia after mitral valve repair. Lancet 1996; 347: 765.
33. Lòpez-Minguez JR, Eldoayen-Gragera J, Gonzàles- Fernàndez R, Fernández-Vegas C, Fuentes-Cañamero ME, Millán-Nuñez V, Nogales-Asensio JM, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with Amplatzer Cardiac Plug. Rev Esp Cardiol 2012 (http://dx.doi.org/10.1016/j.rec. 2012.04.017 [Epub ahead of print])
34. Munkholm-Larsen S, Cao C, Yan TD, Pehrson S, Dixen U,. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: A systematic review. Heart 2012; 98: 900-907.